Search Results - "Bygdeman, M"

Refine Results
  1. 1

    Mid-trimester induced abortion: a review by Lalitkumar, S., Bygdeman, M., Gemzell-Danielsson, K.

    Published in Human reproduction update (2007)
    “…Mid-trimester abortion constitutes 10–15% of all induced abortion. The aim of this article is to provide a review of the current literature of mid-trimester…”
    Get full text
    Journal Article
  2. 2

    Effects of misoprostol on uterine contractility following different routes of administration by Aronsson, A., Bygdeman, M., Gemzell‐Danielsson, K.

    Published in Human reproduction (Oxford) (01-01-2004)
    “…BACKGROUND: The effect of misoprostol administered by different routes on pregnant uterine contractility was investigated. METHODS: Thirty‐two women with a…”
    Get full text
    Journal Article
  3. 3

    Comparison between oral and vaginal administration of misoprostol on uterine contractility by Danielsson, K.Gemzell, Marions, L, Rodriguez, A, Spur, B.W, Wong, P.Y.K, Bygdeman, M

    Published in Obstetrics and gynecology (New York. 1953) (01-02-1999)
    “…Objective: To compare the degree of absorption and the effect on uterine contractility of the prostaglandin E 1 analogue misoprostol after vaginal and oral…”
    Get full text
    Journal Article
  4. 4

    Comparison of two doses of mifepristone in combination with misoprostol for early medical abortion: a randomised trial

    “…Objectives To compare the efficacy of two different regimens of mifepristone followed by misoprostol for medical abortion in women with menstrual delay of ≤ 35…”
    Get full text
    Journal Article
  5. 5

    The effect of various doses of mifepristone on endometrial leukaemia inhibitory factor expression in the midluteal phase--an immunohistochemical study by Danielsson, K G, Swahn, M L, Bygdeman, M

    Published in Human reproduction (Oxford) (01-06-1997)
    “…Leukaemia inhibitory factor (LIF) is a cytokine which plays an obligatory role in mouse blastocyst implantation. In human endometrium, LIF expression is…”
    Get full text
    Journal Article
  6. 6

    Obstetric care and proneness of offspring to suicide as adults: case-control study by Jacobson, Bertil, Bygdeman, Marc

    Published in BMJ (14-11-1998)
    “…Abstract Objective: To investigate any long term effects of traumatic birth and obstetric procedures in relation to suicide by violent means in offspring as…”
    Get full text
    Journal Article
  7. 7

    Improving cycle control in progestogen-only contraceptive pill users by intermittent treatment with a new anti-progestogen by Gemzell-Danielsson, K., van Heusden, A.M., Killick, S.R., Croxatto, H.B., Bouchard, P., Cameron, S., Bygdeman, M.

    Published in Human reproduction (Oxford) (01-10-2002)
    “…BACKGROUND: The safety and efficacy of the anti-progestogen Org 31710 in improving cycle control in healthy women using the desogestrel progestogen-only pill…”
    Get full text
    Journal Article
  8. 8

    Effect of low weekly doses of mifepristone on ovarian function and endometrial development by Gemzell-Danielsson, K., Westlund, P., Johannisson, E., Swahn, M.-L., Bygdeman, M., Seppälä, M.

    Published in Human reproduction (Oxford) (01-02-1996)
    “…The effect of a low dose of mifepristone (RU486) on ovarian and endometrial function was studied in 14 healthy women. The study included one control and two…”
    Get full text
    Journal Article
  9. 9

    Early luteal phase treatment with mifepristone (RU 486) for fertility regulation by Gemzell-Danielsson, K, Swahn, M L, Svalander, P, Bygdeman, M

    Published in Human reproduction (Oxford) (01-06-1993)
    “…Mifepristone (RU 486) is an antiprogestin which interacts with progesterone at the receptor level. Administration of mifepristone immediately after ovulation…”
    Get more information
    Journal Article
  10. 10

    Hormonal contraception without estrogens by Collins, J, Crosignani, P G

    Published in Human reproduction update (01-07-2003)
    “…The long-term clinical effects of ethinyl estradiol and the impact on environmental safety of the alkylated estrogen components used in combined contraceptive…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Effect of low daily doses of mifepristone on ovarian function and endometrial development by Danielsson, K G, Swahn, M L, Westlund, P, Johannisson, E, Seppälä, M, Bygdeman, M

    Published in Human reproduction (Oxford) (01-01-1997)
    “…The effects of low daily doses of the antiprogestin mifepristone (RU 486) on ovarian and endometrial function were studied. The study included one control…”
    Get full text
    Journal Article
  13. 13

    The effect of the antiprogestin RU 486 on uterine contractility and sensitivity to prostaglandin and oxytocin by Swahn, M L, Bygdeman, M

    “…The effect of RU 486, a steroid acting as an antiprogestin at the receptor level, on uterine contractility and sensitivity to the prostaglandin analogue,…”
    Get more information
    Journal Article
  14. 14

    The effect of antiprogestin on integrin expression in human endometrium : An immunohistochemical study by MARIONS, L, DANIELSSON, K. G, BYGDEMAN, M

    Published in Molecular human reproduction (01-05-1998)
    “…Integrins are cell surface receptors for the extracellular matrix and connect extracellular cell adhesion proteins to cytoskeletal components. Several…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Pharmacokinetics of prostaglandins by Bygdeman, Marc

    “…Naturally occurring prostaglandins (PGs) are rapidly metabolized in the human circulation. For clinical use a number of PG analogues have therefore been…”
    Get full text
    Journal Article
  17. 17

    The effect of RU 486 administered during the early luteal phase on bleeding pattern, hormonal parameters and endometrium by Swahn, M L, Bygdeman, M, Cekan, S, Xing, S, Masironi, B, Johannisson, E

    Published in Human reproduction (Oxford) (01-05-1990)
    “…The purpose of the present study was to investigate the effect of a single dose of RU 486 administered very early in the secretory phase on endometrial…”
    Get more information
    Journal Article
  18. 18

    Once-a-month treatment with a combination of mifepristone and the prostaglandin analogue misoprostol by Swahn, M-L., Bygdeman, M., Jun-kang, Chen, Gemzell-Danielsson, K., Si, Song, Qiu-ying, Yang, Pei-juan, Yang, Mei-ling, Qian, Wei-fang, Chang

    Published in Human reproduction (Oxford) (01-02-1999)
    “…In this two centre study, the efficacy of 200 mg mifepristone orally followed 48 h later by 0.4 mg misoprostol orally for menstrual regulation was…”
    Get full text
    Journal Article
  19. 19

    Chlamydia trachomatis PCR (Cobas Amplicor) in women: endocervical specimen transported in a specimen of urine versus endocervical and urethral specimens in 2-SP medium versus urine specimen only by Airell, A, Ottosson, L, Bygdeman, S M, Carlberg, H, Lidbrink, P, Rudén, A K, Elfgren, K

    Published in International journal of STD & AIDS (01-10-2000)
    “…The sensitivity of Roche Cobas Amplicor Chlamydia trachomatis polymerase chain reaction (PCR) including the internal control (IC) programme to identify…”
    Get more information
    Journal Article
  20. 20

    Hormonal contraception: what is new? by The ESHRE Capri Workshop Group

    Published in Human reproduction update (01-07-2002)
    “…Hormonal contraception has become more effective and more widely used, while the world population has grown from 3000 million in 1960 to 6000 million in 2000…”
    Get full text
    Journal Article